This is where the name comes from. There are different types of leukaemia and the treatment you need depends on which type you have. Hairy cell leukaemia (HCL) is a rare type of chronic leukaemia. It ...

Glaucoma occurs due to optic nerve damage. A common treatment is prescription eye drops. Although eye drops do not cure or reverse vision loss, they can help prevent optic nerve damage. Glaucoma ...

Pilocarpine 2% drops; Cefadroxil tablet 500 mg, Desferrioxamine 500 mg for injection; and Lithium tablets 300 mg. Earlier such extraordinary powers have been invoked by NPPA in 2019 and in 2021 ...

IT major HCL Technologies has given a salary hike of 7 per cent to its employees. The pay increment, which will be effective October 2024, for top performers is up to 12-15 per cent, Chief People ...

The directorate general of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), recently suspended ENTOD Pharmaceuticals’ licence to manufacture and market ...

HCL Technologies share price hit a 52-week high on Tuesday after the company reported better than expected earnings for the second quarter of FY25. HCL Tech shares gained as much as 1.40% to a ...

HCL Tech is actively working to offset the impact through efficiency measures.

India's third largest IT major, HCL Technologies reported an 10.5% year-on-year increase in net profit for Q2 FY25, reaching ₹4,235 crore, surpassing market expectations. However, on a sequential ...

HCL Tech Q2 Results: Company exceeded expectations with an 8.2% YoY revenue increase to Rs 28,862 crore and a 10.5% jump in profit to Rs 4,235 crore. Both figures surpassed analyst estimates. The ...

HCL Technologies Ltd reported its fiscal second quarter earnings with profit at Rs 4,237 crore. (Image/Reuters) HCL Technologies Ltd on Monday reported its fiscal second quarter earnings with ...

HCL Tech Dividend: HCL Technologies' board of directors announced the issue of an interim dividend for the financial year 2024-25, according to the company's BSE filing on Monday, October 14 ...